HOMILADOR AYOLLARDA BRONXIAL ASTMA
Keywords:
Bronxial astma, allergiya, respirator viruslar, kortikosteroidlar, epiteliy qatlami, beta-agonistlar.Abstract
Bronxial astma - nafas yo‘llarining siqilishi bilan tavsiflangan nafas olish kasalligi. Asosiy patogenez ko‘rinishda, shuningdek, atrof-muhit omillari kasalliklariga chalingan shaxslarda uchraydi. Klinik xususiyatlari, belgilari, tashxisi va joriy davolash ko‘rib chiqiladi. Bu kasallikning oqibatlari va davolash yo‘nalishlar ta’riflanadi.
References
Goldstein L.H., Weber-Schöndorfer C., Berkovitch M. Antiasthmatic and cough medication. In: Drugs During Pregnancy and Lactation (Third Edition) Treatment Options and Risk Assessment. Amsterdam: Academic Press; 2015.
Rudra C.B., Williams M.A., Frederick I.O. et al. Maternal asthma and risk of preeclampsia: a casecontrol study. J. Reprod. Med. 2006; 51: 94—100.
Bakhireva L.N., Schatz M., Jones K.L. et al. Organization of Teratol- ogy Information Specialists Collaborative Research Group: Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann. Allergy Asthma Immunol. 2008; 101: 137—43.
Blais L., Kettani F.Z., Forget A. Relationship between maternal asth- ma, its severity and control and abortion. Hum. Reprod. 2013; 28: 908—15.
Breton M.C., Beauchesne M.F., Lemière C. et al. Risk of perinatal mortality associated with asthma during pregnancy. Thorax. 2009; 64: 101—6.
Firoozi F., Lemière C., Ducharme F.M. et al. Effect of maternal mod- erate to severe asthma on perinatal outcomes. Respir. Med. 2010; 104: 1278—87.
Murphy V.E., Wang G., Namazy J.A. et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta- analysis. BJOG. 2013; 120: 812—22.
Aylamazyan E.K., Kulakov V.I., Radzinskiy V.E., Savel’eva G.M., eds. Obstetrics. National Guideline [Akusherstvo. Natsional’noe Ru- kovodstvo]. Moscow: GEOTAR-Media; 2009. (in Russian)
Murphy V.E., Namazy J.A., Powell H. et al. A meta-analysis of ad- verse perinatal outcomes in women with asthma. BJOG. 2011; 118: 1314—23.
Cossette B., Forget A., Beauchesne M.F. et al. Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax. 2013; 68: 724—30.
Murphy V.E., Powell H., Wark P.A. et al. A prospective study of re- spiratory viral infection in pregnant women with and without asthma. Chest. 2013; 144: 420—7.
Forbes R.L., Gibson P.G., Murphy V.E. et al. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax. 2012; 67: 209—14.
Vanders R.L., Gibson P.G., Wark P.A. et al. Alterations in inflamma- tory, antiviral and regulatory cytokine responses in peripheral blood mononuclear cells from pregnant women with asthma. Respirology. 2013; 18: 827—33.
Vasilakis-Scaramozza C., Aschengrau A., Cabral H.J. et al. Asthma drugs and the risk of congenital anomalies. Pharmacotherapy. 2013; 33: 363—8.
Lin S., Munsie J.P., Herdt-Losavio M.L. et al. Maternal asthma medi- cation use and the risk of selected birth defects. Pediatrics. 2012; 129: e317—24.
